Skip to main content

Table 2 Characteristics of patients with CVSS prior to and post-stenting

From: Safety and efficacy comparison between OACs plus single antiplatelet and dual antiplatelet therapy in patients with cerebral venous sinus stenosis poststenting

Items

Pre-stenting

Post-stenting

p-value

Symptoms

 Headache, n (%)

58 (47.5)

4 (3.3)

<  0.001

 Tinnitus, n (%)

31 (25.4)

2 (1.6)

<  0.001

 Visual decline

72 (59.0)

10 (8.2)

<  0.001

 Papilledema, n (%)

85 (69.7)

49 (40.2)

<  0.001

 FPG

3 (3–4)

2 (1–2)

<  0.001

 ICP (mm water column)

293.44 ± 63.19

183.89 ± 26.78

<  0.001

 MPG (mmHg)

8 (8.0–13.0)

0.0 (0.0–0.0)

<  0.001

  1. Abbreviations: CVSS Cerebral venous-sinus stenosis, FPG Frisén papilledema grade, ICP Intracranial pressure, MPG Mean pressure gradient